Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
- Muraro, Paolo A
- Pasquini, Marcelo
- Atkins, Harold L
- Bowen, James D
- Farge, Dominique
- Fassas, Athanasios
- Freedman, Mark S
- Georges, George E
- Gualandi, Francesca
- Hamerschlak, Nelson
- Havrdova, Eva
- Kimiskidis, Vassilios K
- Kozak, Tomas
- MANCARDI, GIOVANNI LUIGI
- Massacesi, Luca
- Moraes, Daniela A
- Nash, Richard A
- Pavletic, Steven
- Ouyang, Jian
- Rovira, Montserrat
- Saiz, Albert
- Simoes, Belinda
- Trnen\ufd, Marek
- Zhu, Lin
- Badoglio, Manuela
- Zhong, Xiaobo
- SORMANI, MARIA PIA
- Saccardi, Riccardo
Publication date
January 2017
DOI Publisher
American Medical Association (AMA) ISSN
2168-6149 Citation count (estimate)
24Abstract
Autologous hematopoietic stem cell transplantation (AHSCT) may be effective in aggressive forms of multiple sclerosis (MS) that fail to respond to standard therapies
Add to ORKG